Shares of Piramal Enterprises plummeted 10 percent to Rs 882.85 on the Bombay Stock Exchange (BSE) during Wednesday’s intra-day trading, following the company’s announcement of its financial results for the June 2024 quarter (Q1FY25). The sharp decline in stock price reflects investor concerns over the company’s substantial year-on-year (YoY) profit drop and the challenges it faces in its…
Biocon, a leading player in the biopharmaceutical industry, has announced impressive financial results for Q1FY25, showcasing a remarkable 550% surge in net profit and a significant 30% increase in revenue.
Key Financial Highlights:
Biocon reported consolidated revenue of INR 4,567 crore for Q1FY25, marking a robust 30% increase from the same period last year. This revenue growth is a testament to…
